Professional Experience
Prof. Girard has a strong background in clinical and academic roles, focusing on patient care and specialized thoracic oncology research.
- Current Position: Head of the Thoracic Oncology Department at Institut Curie, Paris
- Role: Practicing pulmonologist and coordinator of rare thoracic tumor programs in European networks
- Previous Roles: Leadership positions in French and European thoracic oncology networks
- Clinical Focus: Early-stage and locally advanced lung cancers, EGFR-mutated lung tumors, thymic tumors
Academic Contributions
- Professor at Université Versailles Saint-Quentin-en-Yvelines
- Lectures and mentorship for medical students and oncology fellows
- Involvement in clinical and translational research projects to improve thoracic tumor treatments
- Participation in European Reference Networks for rare thoracic cancers (EURACAN)
Areas of Expertise
- Lung Cancer – Management of early-stage and advanced lung cancers, including molecular-targeted therapies
- Thymic Tumors – Thymomas and thymic carcinomas, coordinated through French and European networks
- Rare Thoracic Tumors – Diagnosis and treatment of neuroendocrine tumors and other rare thoracic malignancies
- Immunotherapy – Perioperative immunotherapy strategies for thoracic tumors
Publications and Research
Prof. Girard is actively involved in clinical and translational research to enhance outcomes for thoracic cancer patients. He has contributed to multiple peer-reviewed studies focusing on lung cancer, molecular oncology, and rare thoracic tumors, with the aim of integrating immunotherapy and precision medicine into clinical practice.
Patient Care Philosophy
- Focus on personalized treatment plans tailored to each patient’s tumor profile
- Emphasis on clear communication and patient education regarding treatment options
- Integration of multidisciplinary care teams to ensure comprehensive treatment
- Support for international patients with tailored guidance and care coordination
Professional Affiliations
- Member of French thoracic oncology networks, including RYTHMIC
- Coordinator for rare thoracic tumors within the EURACAN European Reference Network
- Active participation in clinical research consortia for thoracic oncology
FAQs
- Is Nicolas Girard board-certified?
- Yes, Prof. Girard is a certified pulmonologist and medical oncologist with specialization in thoracic oncology in France.
- What types of cancers does he treat?
- He treats lung cancer, thymic tumors, neuroendocrine thoracic tumors, and other rare thoracic malignancies.
- Does he treat international patients?
- Yes, he provides care for both local and international patients at Institut Curie, Paris.
- What is his approach to early-stage lung cancer?
- He utilizes perioperative immunotherapy and precision medicine approaches, often integrating molecular-targeted therapies.
- What languages does Prof. Girard speak?
- He primarily speaks French, with support for international patients through the hospital’s multilingual coordination team.
- How does he manage rare thoracic tumors?
- Through coordination with national and European networks, Prof. Girard ensures access to specialized treatment protocols and clinical trials.
